Skip to Content
MilliporeSigma
  • Regulating the cancer-inducing potential of non-steroidal anti-inflammatory drugs: some lessons from the 1970s and 1980s.

Regulating the cancer-inducing potential of non-steroidal anti-inflammatory drugs: some lessons from the 1970s and 1980s.

Social science & medicine (1982) (1998-02-17)
J Abraham
ABSTRACT

This article systematically examines government regulation of medicines in the U.K. and the U.S. with specific reference to carcinogenic risk assessment. By taking four non-steroidal anti-inflammatory drugs (NSAIDs) as case studies, it is argued that there have been inconsistencies between regulatory practice and the scientific standards supposed to have been upheld by drug regulatory agencies. Moreover, those inconsistencies are shown to form a trend over time which suggests an erosion and neglect of regulatory rigour during the 1980s. This takes the form of awarding the benefit of the many scientific doubts in carcinogenicity testing to manufacturers rather than to patients.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Zomepirac sodium salt
Sign Into View Organizational & Contract Pricing
SKUPack SizeAvailabilityPriceQuantity
25 g
In Stock
Details...
₩116,421
100 g
In Stock
Details...
₩233,450
250 g
In Stock
Details...
₩516,432
500 g
In Stock
Details...
₩963,641
1 kg
In Stock
Details...
₩1,612,125
5 kg
In Stock
Details...
₩5,589,402
25 kg
In Stock
Details...
₩11,934,066
50 kg
Estimated to ship on February 03, 2025
Details...
₩22,508,031